(Q52881948)
Statements
Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients (English)
G Ehninger
U Platzbecker
N Gattermann
D Haase
V Janzen
J Krauter
K Götze
R Schlenk
F Nolte
A Letsch
A Kündgen
M Lübbert
U Germing
M Wermke
H Reinhard
C Weiss
K Lieder
O Leismann
4 November 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference